Empowered Funds
AVXL icon

Empowered Funds’s Anavex Life Sciences AVXL Stock Holding History

Empowered Funds’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$244K Buy
+120,938
New +$334K ﹤0.01% 2139

Other funds holding AVXL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Summit Financial
Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Empowered Funds's AVXL Position: Q3 2026 in Review

Empowered Funds opened a new position in Anavex Life Sciences (AVXL) in Q3 2026: 120,938 shares worth $244K. The stake represents ﹤0.01% of the portfolio and ranks #2139 among its holdings.

126 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • Empowered Funds held 120,938 shares of Anavex Life Sciences worth $244K as of Q3 2026.
  • Anavex Life Sciences was a new Empowered Funds position in Q3 2026.
  • Anavex Life Sciences made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2139 holding.
  • 126 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.